May 31, 2020
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
May 14, 2020
Nordic Nanovector's Betalutin® Receives Positive Opinion for Orphan Drug Designation from EMA for Marginal Zone Lymphoma (MZL)
Apr 17, 2020
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma | US & EU Market Sizes from 2017 to 2030, Details of Marketed & Emerging Therapies Kymriah (Novartis) & KTE-X19 (Gilead Sciences)
Jan 27, 2020
Global B-cell Non-Hodgkin's Lymphoma Market Review 2017-2019 and Forecast 2020-2028
Dec 12, 2019
Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
Dec 09, 2019
Researchers at John Theurer Cancer Center, a Member of the Georgetown Lombardi Comprehensive Cancer Center Consortium, Participated in 46 Studies Presented at the 2019 American Society of Hematology's Annual Meeting & Exposition
Dec 08, 2019
Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Dec 07, 2019
More than Seven-Year Analysis of Early Treatment with IMBRUVICA® (ibrutinib) Monotherapy Showed Improved Progression-Free Survival in Patients with Mantle Cell Lymphoma (MCL) that Relapsed or Were Unresponsive to Prior Regimen
Dec 05, 2019
Cancer Treatment Centers of America Continues Pioneering Efforts in Immuno-Oncology; Doses First Patient in Novel Immunotherapy Clinical Trial
Nov 27, 2019
Global non-hodgkin lymphoma treatment market. to grow with a CAGR of 7.2% over the forecast period from 2019-2025
Nov 08, 2019
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA Seeking Approval of IMBRUVICA® (ibrutinib) in Combination with Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Nov 06, 2019
Viracta Announces Oral Presentation on Lead Program for EBV-associated Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Nov 04, 2019
Ascentage Pharma and Henlius Form a Combination Therapy Strategic Collaboration
Oct 08, 2019
Health Canada approves CALQUENCE® (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma (MCL)
Aug 21, 2019
New Fund to Assist Patients Living with Mantle Cell Lymphoma Opens at the HealthWell Foundation
Aug 11, 2019
A New Model for Lymphoma Drug Discovery
Aug 08, 2019
Having a Parent, Sibling, or Child with Blood Cancer Increases One's Own Risk
Jul 31, 2019
The mantle cell lymphoma therapeutics market at a CAGR of over 7% during the forecast period
Jul 15, 2019
Umbralisib (TG Therapeutics/Rhizen) Drug Overview & Product Profiles 2017-2018 & 2019-2026
Jul 12, 2019
Imbruvica (ibrutinib; AbbVie/Johnson & Johnson) Drug Overview & Product Profiles 2017-2026